Evidence map›Paper›PMID 41018474›Full record

ArticleCureus2025

Longitudinal Assessment of Mental Health Sequelae in COVID-19 Survivors: A Cohort Study.

Garima Misra, Vandana Valluri

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Garima MisraCommunity Medicine, Employees' State Insurance Corporation (ESIC) Medical College and Hospital, Hyderabad, IND.
Vandana ValluriCommunity Medicine, Andhra Medical College, Vishakhapatnam, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe long-term consequences of COVID-19, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), remain incompletely understood. Early studies have highlighted persistent multi-system symptoms, including anxiety, but data beyond one year are limited. This study aimed to evaluate the incidence of anxiety symptoms over three years among COVID-19 survivors. This cohort study aimed to investigate the longitudinal outcomes of COVID-19 survivors, with a focus on the persistence and development of sequelae.  Methods: The study enrolled a cohort of 109 subjects who were admitted with real-time polymerase chain reaction (RT-PCR)-confirmed COVID-19 in a tertiary care hospital in south-central India. Due to the retrospective enrollment in 2023, participants were interviewed to recall their anxiety status at discharge (2021) and one year after discharge (2022). This was followed by a prospective assessment of anxiety, two years (2023), and three years (2024) after discharge. The study involved the collection of quantitative data using a standardized questionnaire based on the Hamilton Anxiety Rating Scale (HAM-A), sent to the subjects via non-contact methods such as digital platforms or telephonic conversations. After data gathering, the data were tabulated on a Microsoft Excel spreadsheet and analyzed with the help of the IBM SPSS trial version 21. Statistical analysis included descriptive statistics, chi-square tests, and ordinal logistic regression.

resultsThe mean age of the study subjects was 36.08 ± 15.31 years, with the majority being females. Corresponding to the time of discharge from the hospital, varying levels of anxiety were found among the participants, with most of them having mild anxiety, followed by severe anxiety and mild to moderate anxiety. The major contributors to the severe as well as mild to moderate anxiety were impaired intellectual abilities, insomnia, and depressed mood. The mean baseline HAM-A score at the time of discharge, one year, two years, and three years after discharge were 17.06 ± 10.71, 10.46 ± 8.38, 4.32 ± 5.21, and 1.13 ± 2.58, respectively.

conclusionLongitudinal follow-up showed a notable improvement in anxiety scores over a period of three years, with the mean score falling drastically at each year, suggesting a positive trend in mental health recovery. Findings support the need for integrated long-term mental health support and the need for primary case mental health screening.

Indexed as

anxiety outcomescovid-19 survivorslongitudinal studymental health recoverypost-acute sequelae (pasc)

Identifiers

PMID41018474
PMCPMC12461670

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.